Identification of essential genes for cancer immunotherapy-Reference-Cited by-同舟云学术

Identification of essential genes for cancer immunotherapy

Published:2017-08 Issue:7669 Volume:548 Page:537-542
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Patel Shashank J.,Sanjana Neville E.,Kishton Rigel J.,Eidizadeh Arash,Vodnala Suman K.,Cam Maggie,Gartner Jared J.,Jia Li,Steinberg Seth M.,Yamamoto Tori N.,Merchant Anand S.,Mehta Gautam U.,Chichura Anna,Shalem Ophir,Tran Eric,Eil Robert,Sukumar Madhusudhanan,Guijarro Eva Perez,Day Chi-Ping,Robbins Paul,Feldman Steve,Merlino Glenn,Zhang Feng,Restifo Nicholas P.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature23477.pdf

Reference49 articles.

1. Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214–218 (2013)

2. Chan, T. A., Wolchok, J. D. & Snyder, A. Genetic basis for clinical response to CTLA-4 blockade in melanoma. N. Engl. J. Med. 373, 1984 (2015)

3. Van Allen, E. M. et al. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Science 350, 207–211 (2015)

4. Hugo, W. et al. Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma. Cell 165, 35–44 (2016)

5. Rizvi, N. A. et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science 348, 124–128 (2015)

Cited by 695 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inverse correlation between TP53 gene status and PD-L1 protein levels in a melanoma cell model depends on an IRF1/SOX10 regulatory axis;Cellular & Molecular Biology Letters;2024-09-05

2. Worldwide analysis of actionable genomic alterations in lung cancer and targeted pharmacogenomic strategies;Heliyon;2024-09

3. Mapping spatial organization and genetic cell-state regulators to target immune evasion in ovarian cancer;Nature Immunology;2024-08-23

4. Cell–cell communication: new insights and clinical implications;Signal Transduction and Targeted Therapy;2024-08-07

5. Pharmacological induction of MHC-I expression in tumor cells revitalizes T cell antitumor immunity;JCI Insight;2024-08-06